Wordt geladen...
Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells
Raloxifene hydrochloride (RAL), one of second generation of selective estrogen receptor modulators (SERMs), is usually used in preventing osteoporosis and breast cancer. The present study evaluated whether Raloxifene might sensitize multidrug resistant (MDR) breast cancers to chemotherapies, especia...
Bewaard in:
| Gepubliceerd in: | Cancer Biol Ther |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847829/ https://ncbi.nlm.nih.gov/pubmed/26529585 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1095409 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|